Adenosine mediates transforming growth factor-beta 1 release in kidney glomeruli of diabetic rats

FEBS Letters

Volumn 583, Issue 19, 2009, Pages 3192-3198

  Roa, H ^a   Gajardo, C ^a   Troncoso, E ^a   Fuentealba, V ^a   Escudero, C ^b   Yanez A ^a   Sobrevia, L ^b   Pastor Anglada, M ^c   Quezada, C ^a   San Martin, R ^a  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b Department of Obstetrics and Gynaecology   (Chile)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Adenosine receptor; Diabetic nephropathy; Glomerulus; Transforming growth factor beta 1

Indexed keywords

ADENOSINE; ADENOSINE A2B RECEPTOR; ADENOSINE PHOSPHATE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETES MELLITUS; EX VIVO STUDY; GLOMERULOSCLEROSIS; GLOMERULUS; HYDROLYSIS; MALE; NONHUMAN; NUCLEOTIDE TRANSPORT; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

ADENOSINE; ADENOSINE MONOPHOSPHATE; ANIMALS; BIOLOGICAL AVAILABILITY; DIABETIC NEPHROPATHIES; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; HYDROLYSIS; KIDNEY GLOMERULUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2B; TRANSFORMING GROWTH FACTOR BETA;

RATTUS;

EID: 70349581705     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.09.003     Document Type: Article

References (34)

1. Gross J.L., de Azevedo M.J., Silveiro S.P., Canani L.H., Caramori M.L., and Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28 (2005) 164-176
2. Ziyadeh F.N. Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy. Diabetes Res. Clin. Pract. 82 (2008) S38-S41
3. Hayashida T., and Schnaper H.W. High ambient glucose enhances sensitivity to TGF-β1 via extracellular signal-regulated kinase and protein kinase C δ activities in human mesangial cells. J. Am. Soc. Nephrol. 15 (2004) 2032-2041
4. Isono M., Mogyorósi A., Han D.C., Hoffman B.B., and Ziyadeh F.N. Stimulation of TGF-β1 type II receptor by high glucose in mouse mesangial cells and in diabetic kidney. Am. J. Physiol. 278 (2000) F830-F838
5. Li J.H., Huang X.R., Zhu H.J., Johnson R., and Lan H.Y. Role of TGF-β1 signaling in extracellular matrix production under high glucose conditions. Kidney Int. 63 (2003) 2010-2019
6. Poczatek M.H., Hugo C., Darley-Usmar V., and Murphy-Ullrich J.E. Glucose stimulation of transforming growth factor-β1 bioactivity in mesangial cells is mediated by thrombospondin-1. Am. J. Pathol. 157 (2000) 1353-1363
7. Vallon V., Mühlbauer B., and Osswald H. Adenosine and kidney function. Physiol. Rev. 86 (2006) 901-940
8. Szczepańska-Konkel M., Jankowski M., Stiepanow-Trzeciak A., Rudzik A., Pawełczyk T., and Angielski S. Responsiveness of renal glomeruli to adenosine in streptozotocin-induced diabetic rats dependent on hyperglycaemia level. J. Physiol. Pharmacol. 54 (2003) 109-120
9. Pawelczyk T., Grden M., Rzepko R., Sakowicz M., and Szutowicz A. Region-specific alterations of adenosine receptors expression level in kidney of diabetic rat. Am. J. Pathol. 167 (2005) 315-325
10. Valladares D., Quezada C., Montecinos P., Concha I.I., Yañez A.J., Sobrevia L., and San Martín R. Adenosine A(2B) receptor mediates an increase on VEGF-A production in rat kidney glomeruli. Biochem. Biophys. Res. Commun. 366 (2008) 180-185
11. Gadalla A.E., Pearson T., Currie A.J., Dale N., Hawley S.A., Sheehan M., Hirst W., Michel A.D., Randall A., Hardie D.G., and Frenguelli B.G. AICA riboside both activates AMP-activated protein kinase and competes with adenosine for the nucleoside transporter in the CA1 region of the rat hippocampus. J. Neurochem. 88 (2004) 1272-1282
12. Choi D.S., Cascini M.G., Mailliard W., Young H., Paredes P., McMahon T., Diamond I., Bonci A., and Messing R.O. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat. Neurosci. 7 (2004) 855-861
13. Ackley M.A., Governo R.J., Cass C.E., Young J.D., Baldwin S.A., and King A.E. Control of glutamatergic neurotransmission in the rat spinal dorsal horn by the nucleoside transporter ENT1. J. Physiol. 548 (2003) 507-517
14. Riksen N.P., Rongen G.A., Boers G.H., Blom H.J., Van den Broek P.H., and Smits P. Enhanced cellular adenosine uptake limits adenosine receptor stimulation in patients with hyperhomocysteinemia. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 109-114
15. Carrier E.J., Auchampach J.A., and Hillard C.J. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proc. Natl. Acad. Sci. USA 103 (2006) 7895-7900
16. San Martín R., and Sobrevia L. Gestational diabetes and the adenosine/l-arginine/nitric oxide (ALANO) pathway in human umbilical vein endothelium. Placenta 27 (2006) 1-10
17. Molina-Arcas M., Trigueros-Motos L., Casado F.J., and Pastor-Anglada M. Physiological and pharmacological roles of nucleoside transporter proteins. Nucleos. Nucleot. Nucl. Acid 27 (2008) 769-778
18. Huang D.Y., Vallon V., Zimmermann H., Koszalka P., Schrader J., and Osswald H. Ecto 5′-nucleotidase (cd73)-dependent and -independent generation of adenosine participates in the mediation of tubuloglomerular feedback in vivo. Am. J. Physiol. Renal Physiol. 291 (2006) F282-F288
19. Karczewska J., Martyniec L., Dzierzko G., Stepiński J., and Angielski S. The relationship between constitutive ATP release and its extracellular metabolism in isolated rat kidney glomeruli. J. Physiol. Pharmacol. 58 (2007) 321-333
20. Ruiz-Montasell B., Javier Casado F., Felipe A., and Pastor-Anglada M. Uridine transport in basolateral plasma membrane vesicles from rat liver. J. Membr. Biol. 128 (1992) 227-233
21. Muñoz G., San Martín R., Farias M., Cea L., Vecchiola A., Casanello P., and Sobrevia L. Insulin restores glucose inhibition of adenosine transport by increasing the expression and activity of the equilibrative nucleoside transporter 2 in human umbilical vein endothelium. J. Cell Physiol. 209 (2006) 826-835
22. Fredholm B., IJzerman A., Jacobson K., Klotz K., and Linden J. International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53 (2001) 527-552
23. Park I.S., Kiyomoto H., Abboud S.L., and Abboud H.E. Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46 (1997) 473-480
24. Wahab N.A., Schaefer L., Weston B.S., Yiannikouris O., Wright A., Babelova A., Schaefer R., and Mason R.M. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Diabetologia 48 (2005) 2650-2660
25. Angielski S., Jakubowski Z., Pawelczyk T., Piec G., and Redlak M. Renal handling and metabolism of adenosine in diabetic rats. Contrib. Nephrol. 73 (1989) 52-57
26. Sakowicz M., Szutowicz A., and Pawelczyk T. Insulin and glucose induced changes in expression level of nucleoside transporters and adenosine transport in rat T lymphocytes. Biochem. Pharmacol. 68 (2004) 1309-1320
27. Pawelczyk T., Podgorska M., and Sakowicz M. The effect of insulin on expression level of nucleoside transporters in diabetic rats. Mol. Pharmacol. 63 (2003) 81-88
28. Baldwin S., Yao S., Hyde R., Ng A.M., Foppolo S., Barnes K., Ritzel M.W., Cass C.E., and Young J.D. Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J. Biol. Chem. 280 (2005) 15880-15887
29. Fernández P., Trzaska S., Wilder T., Chiriboga L., Blackburn M.R., Cronstein B.N., and Chan E.S. Pharmacological blockade of A2A receptors prevents dermal fibrosis in a model of elevated tissue adenosine. Am. J. Pathol. 172 (2008) 1675-1682
30. Peng Z., Fernandez P., Wilder T., Yee H., Chiriboga L., Chan E.S., and Cronstein B.N. Ecto 5′-nucleotidase (CD73)-mediated extracellular adenosine production plays a critical role in hepatic fibrosis. FASEB J. 22 (2008) 2263-2272
31. Sun C.X., Zhong H., Mohsenin A., Morschl E., Chunn J.L., Molina J.G., Belardinelli L., Zeng D., and Blackburn M.R. Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J. Clin. Invest. 116 (2006) 2173-2182
32. Martínez-Salgado C., García-Cenador B., Fuentes-Calvo I., Macías Núñez J.F., and López-Novoa J.M. Effect of adenosine in extracellular matrix synthesis in human and rat mesangial cells. Mol. Cell. Biochem. 305 (2007) 163-169
33. 2B receptor in hypoxia. FASEB J. 20 (2006) 2242-2250
34. Makino H., Miyamoto Y., Sawai K., Mori K., Mukoyama M., Nakao K., Yoshimasa Y., and Suga S. Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone. Diabetes 55 (2006) 2747-2756